Your browser doesn't support javascript.
loading
Disrupting PHF8-TOPBP1 connection elicits a breast tumor-specific vulnerability to chemotherapeutics.
Ma, Shuai; Zhang, Jieyou; Guo, Qiushi; Cao, Cheng; Bao, Kaiwen; Liu, Ling; Chen, Charlie Degui; Liu, Zhe; Yang, Jie; Yang, Na; Yao, Zhi; Shi, Lei.
Affiliation
  • Ma S; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Zhang J; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Guo Q; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Cao C; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Bao K; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Liu L; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Chen CD; State Key Laboratory of Molecular Biology, Shanghai Key Laboratory of Molecular Andrology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, China.
  • Liu Z; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Yang J; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Yang N; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Key Laboratory of Medical Data Analysis and Statistical Research of Tianjin, Nankai University, 300353, Tianjin, China. Electronic address: yangnanku@nankai.edu.cn.
  • Yao Z; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
  • Shi L; State Key Laboratory of Experimental Hematology, The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease (Ministry of Educatio
Cancer Lett ; 530: 29-44, 2022 04 01.
Article de En | MEDLINE | ID: mdl-35051531

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription / Tumeurs du sein / Protéines nucléaires / Protéines de transport / Protéines de liaison à l'ADN / Histone Demethylases Type d'étude: Prognostic_studies Limites: Animals / Female / Humans / Male Langue: En Journal: Cancer Lett Année: 2022 Type de document: Article Pays de publication: Irlande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteurs de transcription / Tumeurs du sein / Protéines nucléaires / Protéines de transport / Protéines de liaison à l'ADN / Histone Demethylases Type d'étude: Prognostic_studies Limites: Animals / Female / Humans / Male Langue: En Journal: Cancer Lett Année: 2022 Type de document: Article Pays de publication: Irlande